Richard August Clark

Title: Innovations by Richard August Clark

Introduction

Richard August Clark is an accomplished inventor based in Setauket, NY (US). He has made significant contributions to the field of biomedical research, particularly in the area of wound healing. With a total of 2 patents, his work focuses on enhancing the bioactivity of peptides derived from fibronectin.

Latest Patents

Clark's latest patents include innovative approaches to improve wound healing. One patent details "Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradation." This invention presents polypeptides that are resistant to neutrophil elastase and can bind to growth factors, thereby enhancing their activity. These polypeptides are particularly useful for promoting wound healing in patients. Another significant patent is titled "Methods of treating burns with i.v. cP12 in a window from 2 to 6 hours after injury." This patent outlines a treatment window for administering intravenous cP12 for thermal and chemical burns. Remarkably, it was found that delaying treatment from 2 to 6 hours after wounding, especially around 4 hours, yields superior wound-closing results compared to treatment at 1 hour or after 8 hours.

Career Highlights

Richard Clark is currently associated with Neomatrix Therapeutics Inc., where he continues to develop innovative solutions for wound care. His work has garnered attention for its potential to significantly improve patient outcomes in wound healing.

Collaborations

Clark collaborates with Fubao Lin, contributing to the advancement of their shared research goals.

Conclusion

Richard August Clark's contributions to the field of biomedical research through his patents demonstrate his commitment to improving healthcare solutions. His innovative approaches to wound healing have the potential to make a lasting impact on patient care.